Group One Trading’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $55.1K | Buy |
+22,309
| New | +$47.2K | ﹤0.01% | 5193 |
|
|
2025
Q3 | – | Sell |
-80,702
| Closed | -$225K | – | 8564 |
|
|
2025
Q2 | $178K | Buy |
80,702
+25,236
| +45% | +$41.3K | ﹤0.01% | 4458 |
|
|
2025
Q1 | $64.3K | Sell |
55,466
-38,249
| -41% | -$56.3K | ﹤0.01% | 4954 |
|
|
2024
Q4 | $119K | Buy |
93,715
+90,293
| +2,639% | +$230K | ﹤0.01% | 4369 |
|
|
2024
Q3 | $11.7K | Buy |
+3,422
| New | +$14.9K | ﹤0.01% | 5530 |
|
|
2023
Q1 | – | Sell |
-25,125
| Closed | -$223K | – | 7378 |
|
|
2022
Q4 | $223K | Buy |
25,125
+5,759
| +30% | +$63.2K | ﹤0.01% | 3771 |
|
|
2022
Q3 | $237K | Sell |
19,366
-19,320
| -50% | -$301K | ﹤0.01% | 3970 |
|
|
2022
Q2 | $458K | Sell |
38,686
-56,783
| -59% | -$761K | ﹤0.01% | 3505 |
|
|
2022
Q1 | $1.82M | Buy |
95,469
+72,329
| +313% | +$1.34M | ﹤0.01% | 2495 |
|
|
2021
Q4 | $614K | Sell |
23,140
-11,708
| -34% | -$403K | ﹤0.01% | 3891 |
|
|
2021
Q3 | $1.43M | Sell |
34,848
-43,357
| -55% | -$2.38M | ﹤0.01% | 3009 |
|
|
2021
Q2 | $4.43M | Sell |
78,205
-20,998
| -21% | -$776K | 0.01% | 1809 |
|
|
2021
Q1 | $4.17M | Buy |
+99,203
| New | +$5.65M | 0.01% | 1708 |
|
|
2020
Q4 | – | Sell |
-13,021
| Closed | -$535K | – | 6608 |
|
|
2020
Q3 | $365K | Sell |
13,021
-3,032
| -19% | -$98.8K | ﹤0.01% | 3125 |
|
|
2020
Q2 | $475K | Sell |
16,053
-49,920
| -76% | -$1.3M | ﹤0.01% | 2686 |
|
|
2020
Q1 | $1.31M | Buy |
+65,973
| New | +$1.66M | 0.01% | 1321 |
|
|
2019
Q4 | – | Sell |
-19,984
| Closed | -$499K | – | 5208 |
|
|
2019
Q3 | $454K | Buy |
19,984
+6,886
| +53% | +$171K | ﹤0.01% | 2413 |
|
|
2019
Q2 | $324K | Sell |
13,098
-29,372
| -69% | -$701K | ﹤0.01% | 2511 |
|
|
2019
Q1 | $1.04M | Buy |
42,470
+41,383
| +3,807% | +$937K | 0.01% | 1379 |
|
|
2018
Q4 | $25K | Buy |
+1,087
| New | +$29.6K | ﹤0.01% | 3921 |
|
|
2018
Q1 | – | Sell |
-12,196
| Closed | -$435K | – | 4935 |
|
|
2017
Q4 | $375K | Sell |
12,196
-12,228
| -50% | -$308K | ﹤0.01% | 2485 |
|
|
2017
Q3 | $586K | Sell |
24,424
-33,060
| -58% | -$629K | 0.01% | 1950 |
|
|
2017
Q2 | $965K | Buy |
57,484
+7,262
| +14% | +$131K | 0.01% | 1479 |
|
|
2017
Q1 | $1.12M | Buy |
50,222
+35,404
| +239% | +$734K | 0.01% | 1275 |
|
|
2016
Q4 | $241K | Buy |
14,818
+6,097
| +70% | +$92.5K | ﹤0.01% | 2298 |
|
|
2016
Q3 | $118K | Buy |
+8,721
| New | +$179K | ﹤0.01% | 2831 |
|
Other funds holding EDIT
VCM
VPM
N
OM
Group One Trading's EDIT Position: Q1 2026 in Review
Group One Trading opened a new position in Editas Medicine (EDIT) in Q1 2026: 22,309 shares worth $55.1K. The stake represents ﹤0.01% of the portfolio and ranks #5193 among its holdings. This is a return to the name: Group One Trading previously reported a position in EDIT as recently as Q2 2025.
Group One Trading first reported a position in EDIT in Q3 2016 and has held it in 26 quarters since. The position peaked at $4.43M in Q2 2021. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.
- Group One Trading held 22,309 shares of Editas Medicine worth $55.1K as of Q1 2026.
- Editas Medicine was a new Group One Trading position in Q1 2026.
- Editas Medicine made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5193 holding.
- Group One Trading first reported a position in Editas Medicine in Q3 2016 and has held it in 26 quarters since.
- Group One Trading's Editas Medicine position peaked at $4.43M in Q2 2021.
- 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.